Olin 3Q 2026: Revenue $1.75B, EPS $0.13— 10-Q Summary

Olin reported Q3 2026 revenue of $1.75B, up 2% YoY, but net income fell 66.4% to $14.4M and EPS declined 64.9% to $0.13. Epoxy and Winchester sales rose, while Chlor Alkali products declined. The company expects a challenging Q4 and targets the Huntsman merger for Q1 2027.

Original reporting
Published Oct 30, 2026, 4:31 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 30, 2026, 4:42 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Olin 3Q 2026: Revenue $1.75B, EPS $0.13— 10-Q Summary — source image
Decision brief

The 30-second read

$OLNBearishMed
01

Why it matters

The earnings miss and guidance for a tougher Q4 suggest near‑term downside risk, but segment‑level profit recovery could offer a longer‑term catalyst.

02

Market read

First‑time disclosure of Q3 2026 results provides fresh data for traders; the negative earnings surprise may trigger short‑term price pressure.

03

What to watch

Epoxy segment returned to profit and Winchester sales grew 10%, indicating potential upside if cost trends improve.

Relevance 7/10Novelty 7/10Timing: after-hours

Background

The article is an AI‑generated summary of Olin's 10‑Q filing for Q3 2026.

Company-level read

Ticker impact

$OLNBearishHigh confidence
Context

Olin Corp reported Q3 2026 results with revenue $1.75B and EPS $0.13, a sharp decline from prior year.

Expected impact

likely downside as market prices in lower earnings and challenging Q4 outlook

Evidence & confidence

Revenue grew only 2% YoY while net income fell 66% and EPS dropped 65%; management flagged a tougher fourth quarter.

Market effects

Chemicals sector may see broader pressure as Olin signals higher feedstock costs and competition.

U.S. industrial chemicals market could see modest pullback.

Limited global impact; primarily affects U.S. investors in specialty chemicals.

Counterpoint

If Olin can successfully navigate feedstock cost pressures, the stock may be undervalued after the sell‑off.

Key entities

  • Olin Corp

    U.S. specialty chemicals producer (ticker OLN).

Related articles

$OLNMed

Olin Earnings Call Highlights Merger, Costs and Outlook

Olin Corporation (OLN) reported Q3 earnings, highlighting improved epoxy performance, strong ammunition demand, and merger progress with Huntsman. The company expects $400M in cost synergies from the merger and anticipates a challenging Q4 with adjusted EBITDA of $80M-$100M. Management noted operational disruptions, rising costs, and higher leverage.

$OLNHigh

Olin Corp (OLN) (Q3 2026) Earnings Call Highlights: Q4 Guidance Slumps to $80-$100 Million

Olin Corp (OLN) forecasts Q4 2026 adjusted EBITDA of $80-$100M, down from prior periods, due to higher costs and lower demand. The company expects year-end leverage around 5x, impacted by litigation and merger costs. Caustic soda pricing faces pressure from Chinese exports, while epoxy and ammunition businesses also report challenges. Management expressed confidence in $400M merger synergies and discussed strategies for PVC production and military contracts.

$OLNHighAI 8/10

What Olin (OLN) Said on Its Q3 Earnings Call

Olin (OLN) expects Q4 domestic caustic pricing to decline, with higher turnaround costs in its epoxy segment. Winchester saw improved commercial ammunition demand and $1B in military contract awards. Olin forecasts Q4 adjusted EBITDA of $80M-$100M and full-year 2026 adjusted EBITDA of $550M-$570M, with year-end leverage around 5x. The company maintains a $200M capital spending plan for 2026 and aims for $110M-$120M in cost savings.

$OLNMedAI 8/10

Olin (OLN) Q3 2026 Earnings Call Transcript

Olin (OLN) reported Q3 2026 earnings, highlighting growth in Epoxy and Winchester businesses. Commercial ammunition demand improved, and military contracts increased. The company expects to close its merger with Huntsman in Q1 2027, targeting $400M in cost synergies. Chlor Alkali products saw mixed results, with price increases planned for 2027. The new entity will use the ticker OHN. Olin also secured a new credit agreement to support post-merger liquidity.